Case report about an Innovative non-invasive treatment for patients with Fibromyalgia was published
CHRC researcher and Professor at the Departament of Sports and Health from ESDH/University of Évora, José Parraça participated in the study “Acute effects of a session with the Exopulse Mollii suit in a fibromyalgia patient: a case report” that was published on the International Journal of Environmental Research and Public Health, MDPI.
“Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain and associated fatigue, sleep disturbances, and other cognitive and somatic symptoms. A multidisciplinary approach including pharmacological therapies along with behavioral therapy, exercise, patient education, and pain management is a possible solution for the treatment of this disease.”
Therefore, it was created a case report for an innovative study about the application of a new non-invasive treatment for patients with Fibromyalgia, called EXOPULSE Mollii® method (EXONEURAL NETWORK AB, Danderyd, Sweden). This treatment counts on an innovative approach through a full-body suit that contains multiple electrodes that self-administers electrical stimulation. This case report study has the main goal to evaluate the effects that a 60 minute session with the EXOPULSE Mollii suit has on a female fibromyalgia patient. After some tests and applications of the treatment, the outcome brought positive results on pain perception, muscle oxygenation, parasympathetic modulation, and function in a female fibromyalgia patient.
This study was conducted by CHRC researcher José Parraça along with Alejandro Rubio-Zarapuz (Faculty of Sports Sciences, Universidad Europea de Madrid), María Dolores Apolo-Arenas (Facultad de Medicina y Ciencias de la Salud, Universidad de Extremadura), Vicente Javier Clemente-Suárez (Faculty of Sports Sciences, Universidad Europea de Madrid), Ana Rodrigues Costa (Department of Medical and Health Sciences from ESDH/UÉ) and David Pardo-Caballero (AlgeaSalud, Clinica Neurorrehabilitación Deportiva, Badajoz) .
Learn more about the details of this case report here: https://www.mdpi.com/1660-4601/20/3/2209